tiprankstipranks
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
US Market

Compare Mineralys Therapeutics, Inc. (MLYS) vs. Competitors

591 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Mineralys Therapeutics, Inc.
$26.62
$2.19B
-22.67
118.38%
6 Buy
0 Hold
0 Sell
Strong Buy
Viking Therapeutics
$34.26
$3.96B
-6.36
59.20%
12 Buy
0 Hold
0 Sell
Strong Buy
Xenon
$58.40
$5.59B
-10.27
90.04%
19 Buy
0 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$40.79
$5.21B
-13.43
117.08%
3 Buy
16 Hold
0 Sell
Hold
NewAmsterdam Pharma Company
$34.76
$4.00B
-19.69
133.29%
11 Buy
0 Hold
0 Sell
Strong Buy
Centessa Pharmaceuticals
$39.48
$5.89B
-17.18
250.31%
3 Buy
7 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MLYS
Mineralys Therapeutics, Inc.
26.62
13.22
98.66%
VKTX
Viking Therapeutics
34.26
12.04
54.19%
XENE
Xenon
58.40
27.00
85.99%
APLS
Apellis Pharmaceuticals
40.79
21.37
110.04%
NAMS
NewAmsterdam Pharma Company
34.76
19.64
129.89%
CNTA
Centessa Pharmaceuticals
39.48
27.91
241.23%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts